JP2016056184A5 - - Google Patents

Download PDF

Info

Publication number
JP2016056184A5
JP2016056184A5 JP2015254522A JP2015254522A JP2016056184A5 JP 2016056184 A5 JP2016056184 A5 JP 2016056184A5 JP 2015254522 A JP2015254522 A JP 2015254522A JP 2015254522 A JP2015254522 A JP 2015254522A JP 2016056184 A5 JP2016056184 A5 JP 2016056184A5
Authority
JP
Japan
Prior art keywords
pde1
pyrazolo
inhibitor
pyrimidin
dione
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015254522A
Other languages
English (en)
Japanese (ja)
Other versions
JP6224063B2 (ja
JP2016056184A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2016056184A publication Critical patent/JP2016056184A/ja
Publication of JP2016056184A5 publication Critical patent/JP2016056184A5/ja
Application granted granted Critical
Publication of JP6224063B2 publication Critical patent/JP6224063B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015254522A 2009-10-08 2015-12-25 ホスホジエステラーゼ1−標的トレーサーおよび方法 Active JP6224063B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24985509P 2009-10-08 2009-10-08
US61/249,855 2009-10-08

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012533137A Division JP2013507360A (ja) 2009-10-08 2010-10-07 ホスホジエステラーゼ1−標的トレーサーおよび方法

Publications (3)

Publication Number Publication Date
JP2016056184A JP2016056184A (ja) 2016-04-21
JP2016056184A5 true JP2016056184A5 (enExample) 2017-06-15
JP6224063B2 JP6224063B2 (ja) 2017-11-01

Family

ID=43857046

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012533137A Withdrawn JP2013507360A (ja) 2009-10-08 2010-10-07 ホスホジエステラーゼ1−標的トレーサーおよび方法
JP2015254522A Active JP6224063B2 (ja) 2009-10-08 2015-12-25 ホスホジエステラーゼ1−標的トレーサーおよび方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2012533137A Withdrawn JP2013507360A (ja) 2009-10-08 2010-10-07 ホスホジエステラーゼ1−標的トレーサーおよび方法

Country Status (4)

Country Link
US (2) US8858911B2 (enExample)
EP (1) EP2485771A4 (enExample)
JP (2) JP2013507360A (enExample)
WO (1) WO2011043816A1 (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101248050B (zh) 2005-06-06 2013-07-17 武田药品工业株式会社 有机化合物
KR20090042227A (ko) 2006-06-06 2009-04-29 인트라-셀룰라 써래피스, 인코퍼레이티드. 유기 화합물
US9006258B2 (en) 2006-12-05 2015-04-14 Intra-Cellular Therapies, Inc. Method of treating female sexual dysfunction with a PDE1 inhibitor
WO2009075784A1 (en) 2007-12-06 2009-06-18 Intra-Cellular Therapies, Inc. Organic compounds
AU2008331833A1 (en) * 2007-12-06 2009-06-11 Intra-Cellular Therapies, Inc Organic compounds
CN102232077A (zh) 2008-12-06 2011-11-02 细胞内治疗公司 有机化合物
CN102223799A (zh) 2008-12-06 2011-10-19 细胞内治疗公司 有机化合物
EP2367429B1 (en) 2008-12-06 2017-06-07 Intra-Cellular Therapies, Inc. Organic compounds
EP2358204B1 (en) 2008-12-06 2015-08-05 Intra-Cellular Therapies, Inc. 4,5,7,8-tetrahydro-4-oxo-2H-imidazo[1,2-a]pyrrolo[3,4-e]pyrimidine compounds as PDE1 inhibitors.
KR20110098731A (ko) 2008-12-06 2011-09-01 인트라-셀룰라 써래피스, 인코퍼레이티드. 유기 화합물
WO2010065147A1 (en) 2008-12-06 2010-06-10 Intra-Cellular Therapies, Inc. Organic compounds
EP2400970A4 (en) 2009-02-25 2012-07-18 Intra Cellular Therapies Inc PDE-1-HEMMER FOR EYE DRESSING
US9468637B2 (en) 2009-05-13 2016-10-18 Intra-Cellular Therapies, Inc. Organic compounds
WO2011153135A1 (en) 2010-05-31 2011-12-08 Intra-Cellular Therapies, Inc. Organic compounds
JP5911854B2 (ja) 2010-05-31 2016-04-27 イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. 有機化合物
JP5879336B2 (ja) 2010-05-31 2016-03-08 イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. 有機化合物
TW201206937A (en) 2010-05-31 2012-02-16 Intra Cellular Therapies Inc Organic compounds
US10561656B2 (en) 2011-06-10 2020-02-18 Intra-Cellular Therapies, Inc. Organic compounds
AR091507A1 (es) 2012-06-21 2015-02-11 Intra Cellular Therapies Inc SALES DE (6aR,9aS)-5,6a,7,8,9,9a-HEXAHIDRO-5-METIL-3-(FENILAMINO)-2-((4-(6-FLUOROPIRIDIN-2-IL)FENIL)METIL)-CICLOPENT[4,5]IMIDAZO[1,2-a]PIRAZOLO[4,3-e]PIRIMIDIN-4(2H)-ONA
US9801882B2 (en) 2013-02-17 2017-10-31 Intra-Cellular Therapies, Inc. Phosphodiesterase-1 inhibitors and their use in treatment of cardiovascular diseases
EP2968338B1 (en) 2013-03-15 2019-01-09 Intra-Cellular Therapies, Inc. Pde1 inhibitors for use in the treatment and/or prevention of cns injuries, and pns diseases, disorders or injuries
ES2836129T3 (es) 2013-03-15 2021-06-24 Intra Cellular Therapies Inc Compuestos orgánicos
EP3010509B1 (en) 2013-06-21 2021-07-28 Intra-Cellular Therapies, Inc. Free base crystals
JP6696904B2 (ja) 2014-01-08 2020-05-20 イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. 製剤および医薬組成物
US9884872B2 (en) 2014-06-20 2018-02-06 Intra-Cellular Therapies, Inc. Organic compounds
ES2745819T3 (es) 2014-08-07 2020-03-03 Intra Cellular Therapies Inc Derivados de imidazo[1,2-a]-pirazolo[4,3-e]-pirimidin-4-ona con actividad inhibidora de la PDE1
US9546175B2 (en) 2014-08-07 2017-01-17 Intra-Cellular Therapies, Inc. Organic compounds
US10285992B2 (en) 2014-08-07 2019-05-14 Intra-Cellular Therapies, Inc. Combinations of PDE1 inhibitors and NEP inhibitors and associated methods
EP3193878B1 (en) 2014-09-17 2021-01-06 Intra-Cellular Therapies, Inc. 7,8-dihydro-[2h]-imidazo-[1,2-a]pyrazolo[4,3-e]pyrimidin-4(5h)-one derivatives as phosphodiesterase 1 (pde1) inhibitors for treating diseases, disorders or injuries of the central nervous system (cns)
HK1243936A1 (zh) 2014-12-06 2018-07-27 Intra-Cellular Therapies, Inc. 有机化合物
HK1243935A1 (zh) 2014-12-06 2018-07-27 Intra-Cellular Therapies, Inc. 有机化合物
JP2019510039A (ja) 2016-03-28 2019-04-11 イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. 新規組成物および方法
JP7134168B6 (ja) 2016-09-12 2024-02-02 イントラ-セルラー・セラピーズ・インコーポレイテッド 新規使用
EP3746081A4 (en) 2018-01-31 2021-10-27 Intra-Cellular Therapies, Inc. Novel uses
EP4413980A3 (en) 2019-09-03 2024-10-30 Intra-Cellular Therapies, Inc. Novel compounds
US12435093B2 (en) 2020-05-06 2025-10-07 Intra-Cellular Therapies, Inc. Free base crystals
US12364695B2 (en) 2020-06-02 2025-07-22 Intra-Cellular Therapies, Inc. Methods of treating inflammatory disease

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6334997B1 (en) * 1994-03-25 2002-01-01 Isotechnika, Inc. Method of using deuterated calcium channel blockers
CN101248050B (zh) * 2005-06-06 2013-07-17 武田药品工业株式会社 有机化合物
KR20090042227A (ko) * 2006-06-06 2009-04-29 인트라-셀룰라 써래피스, 인코퍼레이티드. 유기 화합물
WO2008063505A1 (en) * 2006-11-13 2008-05-29 Intra-Cellular Therapies, Inc. Organic compounds
US9006258B2 (en) 2006-12-05 2015-04-14 Intra-Cellular Therapies, Inc. Method of treating female sexual dysfunction with a PDE1 inhibitor
DK2152712T3 (da) * 2007-05-11 2012-03-26 Pfizer Aminoheterocykliske fobindelser
AU2008331833A1 (en) 2007-12-06 2009-06-11 Intra-Cellular Therapies, Inc Organic compounds
WO2009075784A1 (en) 2007-12-06 2009-06-18 Intra-Cellular Therapies, Inc. Organic compounds
US20120070443A1 (en) * 2008-12-02 2012-03-22 University Of Utah Research Foundation Pde1 as a target therapeutic in heart disease
EP2367429B1 (en) 2008-12-06 2017-06-07 Intra-Cellular Therapies, Inc. Organic compounds
EP2358204B1 (en) 2008-12-06 2015-08-05 Intra-Cellular Therapies, Inc. 4,5,7,8-tetrahydro-4-oxo-2H-imidazo[1,2-a]pyrrolo[3,4-e]pyrimidine compounds as PDE1 inhibitors.
KR20110098731A (ko) 2008-12-06 2011-09-01 인트라-셀룰라 써래피스, 인코퍼레이티드. 유기 화합물
CN102223799A (zh) 2008-12-06 2011-10-19 细胞内治疗公司 有机化合物
WO2010065147A1 (en) 2008-12-06 2010-06-10 Intra-Cellular Therapies, Inc. Organic compounds
CN102232077A (zh) 2008-12-06 2011-11-02 细胞内治疗公司 有机化合物
EP2400970A4 (en) 2009-02-25 2012-07-18 Intra Cellular Therapies Inc PDE-1-HEMMER FOR EYE DRESSING
US9468637B2 (en) 2009-05-13 2016-10-18 Intra-Cellular Therapies, Inc. Organic compounds
KR101173440B1 (ko) * 2010-11-05 2012-08-16 (주)토마토시스템 서브그리드의 통합 트랜잭션 처리방법 및 이를 기록한 기록매체

Similar Documents

Publication Publication Date Title
JP6224063B2 (ja) ホスホジエステラーゼ1−標的トレーサーおよび方法
JP2016056184A5 (enExample)
US20220202963A1 (en) Radiolabeled compounds
TW200804363A (en) Novel radioligands
JP7752201B2 (ja) 放射性標識カンナビノイド受容体2リガンド
WO2009045535A2 (en) Fluorine-18 derivative of dasatinib and uses thereof
Cappelli et al. Synthesis, labeling, and biological evaluation of halogenated 2-quinolinecarboxamides as potential radioligands for the visualization of peripheral benzodiazepine receptors
Prabhakaran et al. Synthesis, in vitro and in vivo evaluation of [11C] MMTP: a potential PET ligand for mGluR1 receptors
US10561748B2 (en) Anthranilic acid derivatives
JP4554202B2 (ja) 放射性標識神経ペプチドyy5受容体拮抗薬
US10865195B2 (en) Pet imaging agents
WO2012131037A1 (en) Radiolabelled flumazenil derivatives
EP3339309B1 (en) Radioactive halogen-labeled pyrido[1,2-a]benzimidazole derivative compound
ES2899679T3 (es) Agentes de formación de imágenes
KR101441406B1 (ko) 디아릴이오도늄 염 전구체를 이용한 플로오린-18이 표지된 플루마제닐의 제조 방법
Cao et al. Synthesis and preliminary evaluation of 131I-9-iodovinyl-tetrabenazine targeting vesicular monoamine transporter 2
Homes The development of radiolabelled peripheral benzodiazepine receptor ligands for imaging cancer and neurodegenerative disorders
EP2212320A1 (en) Chemical synthesis of i-124beta cit iodine-124 [2-beta-carbomethoxy-3beta- (4. -iodophenyl) -tropane] for pet investigations and for radiotherapy